Nesiritide acetate | CAS:114471-18-0

We serve Nesiritide acetate CAS:114471-18-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Nesiritide acetate

Chemical Name:Nesiritide acetate
CAS.NO:114471-18-0
Synonyms:Nesiritide acetate
BNP-32
BNP (1-32),HUMAN
 
Physical and Chemical Properties:
Density 1.529 g/cm3
Molecular Formula C143H244N50O42S4
Molecular Weight 3464.04000
Index of Refraction 1.679
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Nesiritide (Natrecor) is the recombinant form of the 32 amino acid human B-type natriuretic peptide, which is normally produced by the ventricular myocardium. Nesiritide works to facilitate cardiovascular fluid homeostasis through counterregulation of the renin-angiotensin-aldoesterone system, stimulating cyclic guanosine monophosphate, leading to smooth muscle cell relaxation.



Contact us for information like Nesiritide acetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,BNP (1-32),HUMAN physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Nesiritide acetate Use and application,BNP (1-32),HUMAN technical grade,usp/ep/jp grade.


Related News: New Zealand citizens and permanent residents and their immediate family members will still be able to enter — but must self-isolate for 14 days after arriving back into the country.Phenyltrimethoxysilane manufacturer The monthly injection to suppress the virus that causes AIDS was aimed as an alternative to daily pills.2-Fluoro-6-nitrobenzoic acid supplier The monthly injection to suppress the virus that causes AIDS was aimed as an alternative to daily pills.2-Fluoro-3-nitropyridine vendor After testing, our quality assurance staff confirms that everything has been performed correctly in accordance with GMP from manufacturing of API to quality testing.INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.